Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgA

Research in Virology

Volumn 147, Issue 1, 1996, Pages 53-66

  Dopatka, H D ^a   Schuy, W ^a  

^a Behringwerke AG   (Germany)

Author keywords

CLL; Compact diagnosis; EBV; EBV reactivation; ELISA; HIV; IgA; IgG; IgM; Infectious mononucleosis; Polyclonal IgM response; Standardization

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STANDARDIZATION;

EID: 0029881064     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2516(96)80240-8     Document Type: Article

References (34)

1. Chalupa, P., Slesinger, P. & Krchnáková, A. (1992), The importance of IgA class antibody against capsid antigen of Epstein-Barr virus. Scripta medica, 65, 113-119.
2. Cheng, H.-M., Foong, Y.-T., Sam, C.-K., Prasad, U. & Dillner, J. (1991), Epstein-Barr nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors. J. Clin. Microbiol., 29, 2180-2186.
3. Costa, S., Barasso, R., Terzano, P., Zerbini, M., Carpi, C. & Musiani, M. (1985), Detection of active Epstein-Barr infection in pregnant women. Eur. J. Clin. Microbiol., 4, 335-336.
4. Coyle, P.V., Wyatt, D., Connolly, J.H. & Lynch, G.A. (1987), Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma in Northern Ireland. Ir. I. Med. Sci., 156, 182-184.
5. Dölken, G., Weitzmann, U., Boldt, C., Bitzer, M., Brugger, W. & Löhr, G.W. (1984), Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA. J. Immunol. Meth., 68, 331-339.
6. Dopatka, H.D. & Giesendorf, B. (1992), Single point quantification of antibody by ELISA without need of a reference curve. J. Clin. Lab. Anal., 6, 417-422.
7. Edwards, J.M.B. & Woodroof, M. (1979), EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages. J. Clin. Pathol., 32, 1036-1040.
8. Galen, R.S. & Gambino, S.R. (1979), in "Norm und Normalabweichung klinischer Daten" (p. 85). G. Fischer Verlag Stuttgart, New York.
9. Gutierrez, J., Del Carmen Maroto, M. & Piédrola, G. (1994), Evaluation of a new reagent for anti-cytomegalovirus and anti-Epstein-Barr virus immunoglobulin G. J. Clin. Microbiol., 32, 2603-2605.
10. Hadar, T., Rahima, M., Kahan, E., Sidi, J., Rakowsky, E., Sarov, B. & Sarov, I. (1986), Significance of specific Epstein-Barr virus IgA and elevated IgG to viral capsid antigens in nasopharyngeal carcinoma patients. J. Med. Virol., 20, 329-339.
11. Hampar, B. (1979), Activation of the viral genome in vitro, in "The Epstein-Barr virus" (M.A. Epstein & B.G. Achong) (pp. 283-295). Springer Verlag, Berlin, Heidelberg, New York.
12. Henle, W., Henle, G., Andersson, J., Ernberg, I., Klein, G., Horwitz, C.A., Marklund, G., Rymo, L., Wellinder, C. & Straus, S.E. (1987), Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc. Natl. Acad. Sci. USA, 84, 570-574.
13. Hofmann, J. & Pustowoit, B. (1994), Vergleichstestungen von EBV-EIA-Systemen mit Immunfluoreszenztesten. In-vitro Diagnostica Nachrichten, 2, 5.
14. Kozlowski, P.A. & Jackson, S. (1992), Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA-1 antibodies mainly directed at env glycoproteins. AIDS Res. Human Retrovir., 8, 1773-1780.
15. Luka, J., Chase, R.C. & Pearson, G.R. (1984), A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. -I. Correlation between ELISA and immunofluorescence titers using purified antigens. J. Immunol. Meth., 67, 145-156.
16. Maréchal, V., Meyohas, M.C., Joab, I., Gaha, S., Giot, J.F., Sergeant, A. & Nicolas, J.C. (1993), Enzyme-linked immunosorbent assay for antibodies to ZEBRA, an Epstein-Barr trans-activator. Res. Virol., 144, 397-404.
17. Masucci, G., Mellstedt, H., Masucci, M.G., Szigeti, R., Ernberg, I., Björkholm, M., Taukuda, K., Henle, G., Henle, W., Pearson, G., Holm, G., Biberfeld, P., Johannsson, B. & Klein, G. (1984), Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr-virus-associated antigens. Canc. Res., 44, 1288-1300.
18. Niller, H.H. & Wolf, H. (1993), Das Epstein-Barr Virus. Zbl. Hyg., 194, 118-125.
19. Pearson, G.R. (1988), ELISA tests and monoclonal antibodies for EBV. J. Virol. Meth., 21, 97-104.
20. Pozetto, B., Mbida, A.D., Grattard, F., Bourlet, T. & Bonnevial, L. (1995), Comparison of eight commercial tests using Epstein-Barr (EBV) virus-specific or non-specific serology for the diagnosis of infectious mononucleosis (IM), European Group for Rapid Viral Diagnosis, Joint Meeting Prague, 10-14. September, PA/66.
21. Röckel, D. & Müller-Lantzsch, N. (1985), Biochemical characterization of two Epstein-Barr-virus early-antigen-associated phosphopolypeptides. Virology, 147, 253-263.
22. Sánchez-Martínez, D., Patton, J.L., Stewart, J.A. & Pellet, P.E. (1995), Detection of Epstein-Barr virus-specific antibodies by means of baculovirus-expressed EBV gp125. J. Virol. Meth., 52, 145-153.
23. Schattner, A. & Rager-Zisman, B. (1990), Virus-induced autoimmunity. Reviews Infi. Dis., 12, 204-222.
24. Schennach, H., Mayersbach, P. & Schönitzer, D. (1994), Increased prevalence of IgM antibodies to Epstein-Barr virus and Parvovirus B19 in blood donations with above-normal Neopterin concentration. Clinical Chemistry, 40, 2104-2105.
25. Schillinger, M., Kampmann, M., Henninger, K., Murray, G., Hanselmann, I. & Bauer, G. (1993), Variability of humoral immune response to acute Epstein-Barr virus (EBV) infection: evaluation of the significance of serological markers. Med. Microbiol. Lett., 2, 296-303.
26. Schneider, H., Jobke, A. & Pernice, W. (1985), Persistierende Epstein-Barr-virus-Infektion. Monatsschr. Kinderheilkd., 133, 897-900.
27. Sigel, G., Schillinger, M., Henninger, K. & Bauer, G. (1994), IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma. J. Med. Virol., 43, 222-227.
28. Thiele, G.M. (1993), Diagnosis of Epstein-Barr virus infections in the clinical laboratory. Clin. Microbiol. Newsletter, 15, 41-46.
29. Van Grunsven, W.M., Nabbe, A. & Middeldorp, J.M. (1993), Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex. J. Med. Virol., 40, 161-169.
30. Van Renterghem, A.M., Van den Abeele, J. & Plum, J. (1994), Evaluation of 3 commercial ELISA systems for diagnosis of primary EBV infection in children 2 to 6 years. European Group for Rapid Viral Diagnosis, Joint Meeting Stockholm, 14-18. August, P2/09.
31. Vincent, C., Cozon, G., Zittoun, M., Mellquist, M., Kazatchkine, M.D., Czerkinsky, C. & Revillard, J.-P. (1992), Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients. J. Clin. Immunol., 12, 381-388.
32. Ward, K.N., Sheldon, M.J. & Gray, J.J. (1991), Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence for virus interaction. J. Med. Virol., 34, 258-267.
33. Wiedbrauk, D.L. & Bassin, S. (1993), Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr-virus viral capsid antigens. J. Clin. Microbiol., 31, 1339-1341.
34. Zeng, Y., Zhong, J.M., Li, L.Y., Wang, P.Z., Tang, H., Ma, Y.R., Zhu, J.S., Pan, W.J., Liu, Y.X., Wei, Z.N., Chen, J.Y., Mo, Y.K., Li, E.J. & Tan, B.F. (1983), Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirol., 20, 190-194.